STERIALS

The company will develop and commercialize products that enable accurate and rapid molecular testing for infectious and other diseases at the point of care. The molecular diagnostics platform, consisting of compact devices, single-use test cartridges, and software including a central cloud database, will provide central laboratory level accuracy and be easy to operate even for untrained personnel. Delaware State